BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 75 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,569 | -43.2% | 14,484 | 0.0% | 0.00% | – |
| Q2 2023 | $73,144 | +62.5% | 14,484 | -19.5% | 0.00% | – |
| Q2 2022 | $45,000 | -66.4% | 17,994 | -62.7% | 0.00% | – |
| Q1 2022 | $134,000 | -58.4% | 48,287 | -19.9% | 0.00% | – |
| Q4 2021 | $322,000 | -37.0% | 60,313 | 0.0% | 0.00% | – |
| Q3 2021 | $511,000 | -64.7% | 60,313 | -49.1% | 0.00% | – |
| Q2 2021 | $1,446,000 | -47.9% | 118,583 | +3.6% | 0.00% | -100.0% |
| Q1 2021 | $2,778,000 | -19.8% | 114,506 | +5.9% | 0.00% | 0.0% |
| Q4 2020 | $3,466,000 | +7.6% | 108,127 | +1.5% | 0.00% | 0.0% |
| Q3 2020 | $3,222,000 | -6.0% | 106,569 | +31.2% | 0.00% | -50.0% |
| Q2 2020 | $3,426,000 | +437.0% | 81,255 | +218.0% | 0.00% | – |
| Q1 2020 | $638,000 | – | 25,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,014,858 | $17,046,000 | 0.60% |
| NEA Management Company, LLC | 3,449,845 | $29,186,000 | 0.35% |
| MPM BioImpact LLC | 248,506 | $2,102,000 | 0.33% |
| Artal Group S.A. | 1,646,517 | $13,930,000 | 0.31% |
| RA Capital Management | 2,589,904 | $21,911,000 | 0.30% |
| Bellevue Group AG | 3,463,000 | $29,297,000 | 0.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 760,128 | $6,431,000 | 0.13% |
| Ikarian Capital, LLC | 150,484 | $1,272,000 | 0.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,000 | $371,000 | 0.09% |
| Virtus ETF Advisers LLC | 16,600 | $140,000 | 0.06% |